Package 0069-0238-01

Brand: ruxience

Generic: rituximab-pvvr
NDC Package

Package Facts

Identity

Package NDC 0069-0238-01
Digits Only 0069023801
Product NDC 0069-0238
Product ID 0069-0238_6d7dcd95-bbc2-4b1b-b044-5d6b06e3ca38
Description

1 VIAL, SINGLE-USE in 1 CARTON (0069-0238-01) / 10 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2020-01-23
Brand ruxience
Generic rituximab-pvvr
Sample Package No

Linked Drug Pages (1)

Ruxience ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "6d7dcd95-bbc2-4b1b-b044-5d6b06e3ca38", "openfda": {"nui": ["N0000175078", "N0000175657"], "unii": ["4F4X42SYQ6"], "rxcui": ["2273512", "2273517", "2273520", "2273521"], "spl_set_id": ["f941fc61-f7a3-4e4a-ab7c-87c1667fa05b"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0069-0238-01)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0069-0238-01", "marketing_start_date": "20200123"}], "brand_name": "Ruxience", "product_id": "0069-0238_6d7dcd95-bbc2-4b1b-b044-5d6b06e3ca38", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "0069-0238", "generic_name": "rituximab-pvvr", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ruxience", "active_ingredients": [{"name": "RITUXIMAB", "strength": "100 mg/10mL"}], "application_number": "BLA761103", "marketing_category": "BLA", "marketing_start_date": "20200123", "listing_expiration_date": "20261231"}